They need affordable access to GLP-1 prescriptions for weight loss without insurance barriers
Stevens-Johnson syndrome, toxic epidermal necrolysis, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), alopecia, chloasma, and pruritus have also been reported with spironolactone therapy
A dedicated federal multidistrict litigation has been established specifically for vision loss claims related to semaglutide medications, which is a major sign that courts are taking these injuries seriously
It mimics the action of the glucagon-like peptide-1 (GLP-1) hormone, which stimulates insulin secretion, inhibits glucagon release, slows gastric emptying, and reduces appetite, leading to better blood sugar control and weight loss